B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcome.

Abstract excerpt

Downstream of Ras, the serine/threonine kinase B-raf has recently been reported to be mutated, among other carcinomas, in a majority of melanoma cell lines with a preponderance of mutations within the kinase domain including the activating V599E transition. We therefore investigated a representative number of 50 primary melanoma resection specimens for the presence of mutations within the activation segment (exon...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cloning, Molecular
• Share to Electrophoresis
• Share to Melanoma